Scleroderma and Mitral Stenosis: a New Cardiac Involvement or an Association by Chance

Ahmadreza Zarifian, Alireza Sepehri Shamloo, Mohammad Sobhan Sheikh Andalibi, Hamid Hoseinikhah, Fereshteh Ghaderi, Morteza Khaki, Aliasghar Moeinipour

Abstract


Introduction: Systemic Sclerosis (SSc) is an autoimmune disorder with unknown etiology, which presents with vascular lesions and fibrosis of the skin and internal organs. Cardiac, renal, and pulmonary involvements are major causes of death in systemic sclerosis. Although a major cause of scleroderma deaths is cardiac failure, scleroderma rarely causes valvular disease. This is the eighth global report on scleroderma in company with mitral stenosis and the first one in Iran.

Case report: The patient was a 48-year-old woman with severe mitral stenosis who was diagnosed with scleroderma 6 months before. Echocardiographic assessments had revealed no clinical manifestation of heart involvement in her previous visits. We used cardiac surgical treatment with successful outcome.

Conclusion: The present case confirms the data from the currently available literature, indicating that mitral valve involvement in systemic sclerosis is a rare occurrence. Awareness of this uncommon association and adequate management to prevent complications of the underlying disease are prerequisites for successful mitral valve repair or replacement in such patients.

Keywords


Systemic sclerosis, Mitral stenosis, Cardiac involvement

References


Grimaldi A, De Gennaro L, Chiara Vermi A, Pappalardo F, Daniele Brunetti N, Di Biase M, et al. Cardiac Valve Involvement in Systemic Diseases: A Review. Clinical cardiology. 2013;36(3):117-24.

Karabay CY, Karaahmet T, Tigen K. Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart. Anadolu Kardiyol Derg. 2011;11:643-7.

Plastiras SC, Toumanidis ST. Systemic sclerosis: the heart of the matter. Hellenic J Cardiol. 2012;53(53):287-300.

Perera A, Fertig N, Lucas M, Rodriguez‐Reyna TS, Hu P, Steen VD, et al. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti–topoisomerase I antibody. Arthritis & Rheumatism. 2007;56(8):2740-6.

Lambova S. Cardiac manifestations in systemic sclerosis. World journal of cardiology. 2014;6(9):993.

Evans M, Parker R. Honeycomb lung and mitral stenosis in scleroderma. Thorax. 1954;9(2):154-8.

Shankar O, Pandey V, Malviya K. Scleroderma Associated with Rheumatic Fever : A Case Report. International Journal of Scientific Research. 2014;3(5):437-8.

Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, et al. Cardiac involvement in systemic sclerosis assessed by tissue‐doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis & Rheumatism. 2008;58(6):1803-9.

Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, et al. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti–topoisomerase I antibody. Arthritis & Rheumatism. 2007;56(8):2740-6.

Balaj R, Poanta L, Rednic S. Cardiac involvement in systemic sclerosis. Rom J Intern Med. 2012 Oct-Dec;50(4):269-74.

Cheng K-S, Tiwari A, Boutin A, Denton C, Black C, Morris R, et al. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology. 2003;42(11):1299-305.

Kahan A, Coghlan G, McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford, England). 2009;48:iii45-8.

Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis & Rheumatism. 2008;58(6):1803-9.

Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006 Nov 1;174(9):1034-41.

Distler O, Behrens F, Huscher D, Foeldvari I, Zink A, Nash P, et al. Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Rheumatology. 2006;45(12):1455-7.

Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y. Clinical Implications of Left Atrial Enlargement: A Review. The Ochsner Journal. 2009 Winter;9(4):191-6.

Nakajima K, Taki J, Kawano M, Higuchi T, Sato S, Nishijima C, et al. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement. Journal of Nuclear Medicine. 2001;42(2):183-8.

Allanore Y, Meune C, Vonk M, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of systemic sclerosis patients. Annals of the rheumatic diseases. 2009.

de Groote P, Gressin V, Hachulla E, Carpentier P, Guillevin L, Kahan A, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Annals of the rheumatic diseases. 2008;67(1):31-6.

Steen V. The heart in systemic sclerosis. Current rheumatology reports. 2004;6(2):137-40.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v8i0.261


Copyright (c) 2016 Ahmadreza Zarifian, Alireza Sepehri Shamloo, Mohammad Sobhan Sheikh Andalibi, Hamid Hoseinikhah, Fereshteh Ghaderi, Morteza Khaki, Ali Asghar Moeinipour

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.